Welcome to Ectosome.

We sincerely thank you for your visit to Ectosome.

We are living in an era where the boundaries between AI, nanotechnology, and life sciences are rapidly dissolving. Amid this paradigm shift, Ectosome Co., Ltd. stands at the forefront as an innovative platform-based biotechnology company—decoding the unique biological language of stem cell-derived ectosomes to pioneer the future of precision medicine.

Our core technologies include

• A multi-target drug delivery system designed to simultaneously address pancreatic cancer and metastatic tumors
• A thermal stimulus-based platform for stem cell therapy targeting arthritis
• An AI-powered pipeline for therapeutic candidate discovery, followed by validation in non-human primate models.

Ectosome is bridging science, technology, and human lives by designing next-generation architect of therapeutic innovation.

Our platform technology is offering integrated solutions with scalability, which enables application to a wide range of therapeutic areas. We believe our platform-driven innovation will serve as the foundation for the next era of biomedicine, which will open doors to countless therapeutic opportunities.

We invite you to be part of this journey—bringing your insight, passion, and vision along the way.

Thank you.

CEO, Ectosome Inc.